Volume 6.06 | Feb 21

Immune Regulation News 6.06 February 21, 2014
Immune Regulation News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  Immune Regulation News on Twitter
New Blood Cells Fight Brain Inflammation
In the devastating disease multiple sclerosis, hyperactivity of immune cells called T-cells induce chronic inflammation and degeneration of the brain. Researchers have identified a new type of regulatory blood cells that can combat such hyperactive T-cells in blood from patients with multiple sclerosis. [Press release from the University of Copenhagen discussing online prepublication in Nature Medicine] Press Release | Abstract
Free Nature Reviews Immunology Poster: The Immune Response to HIV
PUBLICATIONS (Ranked by impact factor of the journal)
NLRC3, a Member of the NLR Family of Proteins, Is a Negative Regulator of Innate Immune Signaling Induced by the DNA Sensor STING
The authors found that the nucleotide-binding, leucine-rich-repeat-containing protein, NLRC3, reduced STING-dependent innate immune activation in response to cytosolic DNA, cyclic di-GMP, and DNA viruses. [Immunity] Abstract

T Cell Repertoire following Autologous Stem Cell Transplantation for Multiple Sclerosis
In a Phase II study of hematopoietic stem cell transplantation (HSCT) for poor-prognosis multiple sclerosis, scientists used high-throughput deep TCRβ chain sequencing to assess millions of individual TCRs per patient sample. They found that HSCT has distinctive effects on CD4+ and CD8+ T cell repertoires. [J Clin Invest]
Full Article
| Press Release

Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Investigators report on 16 patients with relapsed or refractory B cell acute lymphoblastic leukemia that they treated with autologous T cells expressing the 19-28z chimeric antigen receptor (CAR) specific to the CD19 antigen. [Sci Transl Med] Abstract | Press Release

Targeted Depletion of an MDSC Subset Unmasks Pancreatic Ductal Adenocarcinoma to Adaptive Immunity
The authors showed that selective depletion of one subset of myeloid-derived suppressor cells (MDSC) in an autochthonous, genetically engineered mouse model of pancreatic ductal adenocarcinoma unmasks the ability of the adaptive immune response to engage and target tumor epithelial cells. [Gut] Abstract | Press Release

Prolactin Mediates Psychological Stress-Induced Dysfunction of Regulatory T Cells to Facilitate Intestinal Inflammation
The authors aimed to elucidate a pathological pathway between psychological stress and the dysfunction of regulatory T cells, and its effect on facilitating intestinal inflammation. [Gut] Abstract

Opposing Actions of IL-2 and IL-21 on Th9 Differentiation Correlate with Their Differential Regulation of BCL6 Expression
Researchers show that interleukin 2 (IL-2)-JAK3-STAT5 signaling is required for T-helper 9 (Th9) differentiation, with critical STAT5 binding sites in the gene encoding IL-9 promoter. IL-2 also inhibited B cell lymphoma 6 (BCL6) expression, and overexpression of BCL6 impaired Th9 differentiation. [Proc Natl Acad Sci USA] Abstract

NF-κB Signaling Mediates Homeostatic Maturation of New T Cells
Investigators identified a role for the Nuclear Factor κ-B (NF-κB) signaling pathway in controlling expression of IL-7 receptor α (IL-7Rα) in new T cells. Perturbations to NF-κB signaling, either by deletion of Inhibitor of Kappa-B Kinase-2 or by inhibiting Rel dimer activity, prevented normal IL-7Rα expression in new T cells. [Proc Natl Acad Sci USA] Abstract

Targeting Sirtuin-1 Alleviates Experimental Autoimmune Colitis by Induction of Foxp3+ T-Regulatory Cells
Scientists adoptively transferred CD4+CD25Foxp3 T effector (TE) cells from wild-type (WT) or fl-Sirt1/CD4cre mice into B6/Rag1−/− mice and monitored the mice until they lost 10-15% of their weight. Adoptive transfer of TE cells lacking sirtuin-1 (Sirt1) to B6/Rag1−/− mice resulted in a 2.8-fold increase in induced Forkhead box P3-positive (Foxp3+) T-regulatory cells formation compared with mice receiving WT TE cells and correlated with attenuated colitis and reduced weight loss. [Mucosal Immunol] Abstract

Unique Macrophages Different from M1/M2 Macrophages Inhibit T Cell Mitogenesis while Upregulating Th17 Polarization
There are two major suppressor macrophage (MΦ) subsets (M1 and M2 MΦs) that are phenotypically and functionally different. Researchers examined which of the MΦ subsets the mycobacterial infection-induced suppressor MΦs (MIS-MΦs) belong to. MIS-MΦs down-regulated T cell production of Th1 and Th2 cytokines but markedly increased production of interleukin (IL)-17A and IL-22 through up-regulation of Th17 cell expansion. [Sci Rep] Full Article

Win a $25 Amazon Gift Card!
Connexon Creative is evaluating reader interest in a new social media platform. Fill out this quick survey for your chance to win 1 of 4 $25 gift cards! Take survey here

Subscribe to our sister publications: Human Immunology News and Immunology of Infectious Disease News!

Got cells? Rare progenitor and immune cells ready for your research
Circadian Clock Proteins and Immunity
Studies highlight the extent to which the molecular clock, most notably the core clock proteins BMAL1, CLOCK, and REV-ERBα, control fundamental aspects of the immune response. [Immunity] Abstract

Visit our reviews page to see a complete list of reviews in the immune regulation field.
Cellectis and Servier Announce Collaboration in Allogeneic Cell Therapy: UCART19 to Treat Leukemia and Five Product Candidates Targeting Solid Tumors
Cellectis announced that it has signed a strategic collaboration agreement with Servier to develop and commercialize novel product candidates targeting leukemia and solid tumors. [Cellectis] Press Release

Novartis Expands Cancer Immunotherapy Research Program with Acquisition of CoStim
Novartis announced that it is broadening its cancer immunotherapy research program with the acquisition of CoStim Pharmaceuticals Inc., a privately held biotechnology company focused on harnessing the immune system to eliminate immune-blocking signals from cancer. [Novartis AG] Press Release

From our sponsor: Free human hematopoietic progenitors wallchart. Request your copy.
AAAS Launches Open-Access Journal
Joining a herd of other scientific societies, American Association for the Advancement of Science (AAAS) announced that it will launch the organization’s first online, fully open-access journal early next year. The new journal, called Science Advances, will give authors another outlet for papers that they are willing to pay to make immediately free to the public. [ScienceInsider] Press Release

National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
NEW Cold Spring Harbor Asia Conferences: Frontiers of Immunology in Health and Diseases
September 2-6, 2014
Suzhou, China

Visit our events page to see a complete list of events in the immune regulation community.
NEW PhD Studentship – B Cell and Macrophage Function in Cancer (Karolinska Institutet)

NEW Assistant/Associate Professors – Allergic Inflammation and Sensory Neurobiology (North Carolina State University College of Veterinary Medicine)

PhD Student Position – Molecular Immunology (Institute for Research in Biomedicine)

Principal Investigator – Inflammation Research (Northwestern University)

Assistant Professor – Development of Novel Biologicals for Immune-Based Disorders (Leiden Academic Centre For Drug Research)

Postdoctoral Position – Cell Signaling in the Immune System (Baylor Institute for Immunology Research)

Immunology Research Associate Position (Shanghai Jiaotong University School of Medicine)

Postdoctoral Position – Epigenetic Regulation of Interleukin-12 Family Members (Université Libre de Bruxelles)

PhD Position – Biology/Immunology (Saarland University)

PhD Research Position – Molecular and Cellular Mechanisms of Immune Tolerance and Autoimmunity (Weizmann Institute of Science)

Research Technologist – Pluripotent Stem Cells (STEMCELL Technologies Inc.)

Research Technologist – Particle Chemistry (STEMCELL Technologies Inc.)

Research Technologist – PSC Biology and Bioengineering (STEMCELL Technologies Inc.)

Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Have we missed an important article or publication in Immune Regulation News? Click here to submit!

Comments or Suggestions? Submit your feedback here.
Learn more about Immune Regulation News: Archives | Events | Contact Us